Literature DB >> 12429430

Immune correlate study on human Schistosoma japonicum in a well-defined population in Leyte, Philippines: II. Cellular immune responses to S. japonicum recombinant and native antigens.

Luz P Acosta1, Gary Waine, Gemiliano D L Aligui, Wilfred U Tiu, Remigio M Olveda, Donald P McManus.   

Abstract

Cellular immune responses to specific Schistosoma japonicum recombinant and native antigens were investigated in a defined study population of 155 individuals in the Philippines, where data collected from a 3-year observation of exposure, infection and reinfection pattern were used to categorically classify putative 'resistant' and 'susceptible' individuals. Using peripheral blood mononuclear cells (PBMC) of individuals enrolled in the study, in vitro lymphocyte proliferation and cytokine (IFN-gamma, IL-5 and IL-10) production in response to defined recombinant antigens (97 kDa paramyosin, 22 kDa tegumental antigen, 37 kDa glyceraldehyde-3-phosphate dehydrogenase, 14 kDa fatty acid binding protein and 28 kDa gluthathione-S-tranferase) and native antigen soluble worm antigen preparation (SWAP) were measured. Cellular responses to the recombinant and SWAP antigens suggest that Th1 type of response appear to be important in predicting resistance in this population. Of the five recombinant antigens tested, rPMY induced significant levels of IFN-gamma. The production of IL-10, a Th2-type cytokine was strongly implicated in immune regulation. Of importance was the evidence found for SWAP and rPMY induced IFN-gamma responses in predicting 'resistance'. It was noted that these associations were significant even after the effect of age and sex were accounted for in a multivariate analysis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12429430     DOI: 10.1016/s0001-706x(02)00177-8

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  12 in total

1.  T-helper-2 cytokine responses to Sj97 predict resistance to reinfection with Schistosoma japonicum.

Authors:  Tjalling Leenstra; Luz P Acosta; Hai-Wei Wu; Gretchen C Langdon; Julie S Solomon; Daria L Manalo; Li Su; Mario Jiz; Blanca Jarilla; Archie O Pablo; Stephen T McGarvey; Remigio M Olveda; Jennifer F Friedman; Jonathan D Kurtis
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

2.  Still hope for schistosomiasis vaccine.

Authors:  Alessandra Ricciardi; Momar Ndao
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

3.  Construction and expression of bivalent membrane-anchored DNA vaccine encoding Sjl4FABP and Sj26GST genes.

Authors:  Ping Guo; Wuxing Dai; Shuojie Liu; Ping Yang; Jizhong Cheng; Liang Liang; Zhihao Chen; Hong Gao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

Review 4.  Schistosomiasis in the People's Republic of China: the era of the Three Gorges Dam.

Authors:  Donald P McManus; Darren J Gray; Yuesheng Li; Zheng Feng; Gail M Williams; Donald Stewart; Jose Rey-Ladino; Allen G Ross
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

5.  Inflammatory cytokines IFN-γ, IL-4, IL-13 and TNF-α alterations in schistosomiasis: a meta-analysis.

Authors:  Liping Yu; Xi Sun; Fan Yang; Jie Yang; Jia Shen; Zhongdao Wu
Journal:  Parasitol Res       Date:  2011-10-04       Impact factor: 2.289

6.  Tissue inhibitor of matrix-metalloprotease-1 predicts risk of hepatic fibrosis in human Schistosoma japonicum infection.

Authors:  Valeria Fabre; Haiwei Wu; Sunthorn PondTor; Hannah Coutinho; Luz Acosta; Mario Jiz; Remigio Olveda; Ling Cheng; Eric S White; Blanca Jarilla; Stephen T McGarvey; Jennifer F Friedman; Jonathan D Kurtis
Journal:  J Infect Dis       Date:  2011-01-03       Impact factor: 5.226

7.  Protective and antifecundity effects of Sm-p80-based DNA vaccine formulation against Schistosoma mansoni in a nonhuman primate model.

Authors:  Gul Ahmad; Weidong Zhang; Workineh Torben; Raymond T Damian; Roman F Wolf; Gary L White; Maria Chavez-Suarez; Ronald C Kennedy; Afzal A Siddiqui
Journal:  Vaccine       Date:  2009-03-10       Impact factor: 3.641

Review 8.  Experimental vaccines in animal models for schistosomiasis.

Authors:  Afzal A Siddiqui; Gul Ahmad; Raymond T Damian; Ronald C Kennedy
Journal:  Parasitol Res       Date:  2008-02-08       Impact factor: 2.289

9.  Immuno-epidemiology of human Schistosoma haematobium infection: preferential IgG3 antibody responsiveness to a recombinant antigen dependent on age and parasite burden.

Authors:  Francisca Mutapi; Takafira Mduluza; Natalia Gomez-Escobar; William F Gregory; Cecilia Fernandez; Nicholas Midzi; Rick M Maizels
Journal:  BMC Infect Dis       Date:  2006-06-09       Impact factor: 3.090

10.  Trick or treat: the role of vaccines in integrated schistosomiasis control.

Authors:  Robert Bergquist; Jürg Utzinger; Donald P McManus
Journal:  PLoS Negl Trop Dis       Date:  2008-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.